New Two-Drug combo aims to keep ovarian cancer at bay after chemotherapy
Disease control
Not yet recruiting
This study is testing whether taking two oral medications (fluzoparib and famitinib) as maintenance therapy can help delay the return of advanced ovarian cancer in women who responded well to their initial chemotherapy. The trial will enroll 43 women aged 18-75 who have advanced …
Phase: PHASE2 • Sponsor: Jinhua Zhou • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC